Oxymestane, a cytostatic steroid derivative of exemestane with greater antitumor activity in non-estrogen-dependent cell lines-Reference-Cited by-同舟云学术

Oxymestane, a cytostatic steroid derivative of exemestane with greater antitumor activity in non-estrogen-dependent cell lines

Published:2021-09 Issue: Volume:212 Page:105950
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Pires Ana S.^ORCID,Varela Carla L.,Marques Inês A.^ORCID,Abrantes Ana M.,Gonçalves Cristina^ORCID,Rodrigues Tiago^ORCID,Matafome Paulo^ORCID,Botelho Maria F.^ORCID,Roleira Fernanda M.F.,Tavares-da-Silva Elisiário^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference38 articles.

1. Chapter 1. Privileged Scaffolds in Medicinal Chemistry: An Introduction;Barreiro,2015

2. Role of estramustine phosphate and other estrogens for castration-resistant prostate cancer;Inoue,2018

3. Pharmacokinetic aspects of the two novel oral drugs used for metastatic castration-resistant prostate cancer: abiraterone acetate and enzalutamide;Benoist;Clin. Pharmacokinet.,2016

4. Steroidal anticancer agents: an overview of estradiol-related compounds;Minorics;Anticancer Agents Med. Chem.,2018

5. Current status on development of steroids as anticancer agents;Gupta;J. Steroid Biochem. Mol. Biol.,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Steroidal epoxides as anticancer agents in lung, prostate and breast cancers: The case of 1,2-epoxysteroids;Biochemical Pharmacology;2024-07

2. Exploring Potential Non-steroidal Aromatase Inhibitors for Therapeutic Application against Estrogen-dependent Breast Cancer;Current Computer-Aided Drug Design;2023-08

3. The Structural Diversity and Biological Activity of Steroid Oximes;Molecules;2023-02-10

4. An Exemestane Derivative, Oxymestane-D1, as a New Multi-Target Steroidal Aromatase Inhibitor for Estrogen Receptor-Positive (ER+) Breast Cancer: Effects on Sensitive and Resistant Cell Lines;Molecules;2023-01-12

5. Design, synthesis, and antitumor activity evaluation of steroidal oximes;Bioorganic & Medicinal Chemistry;2021-09